Chronic continuous infusion of (-)nicotine reduces basic fibroblast growth factor messenger RNA levels in the ventral midbrain of the intact but not of the 6-hydroxydopamine-lesioned rat

Neuroscience

Volumn 70, Issue 1, 1996, Pages 169-177

  Blum, M ^a   Wu, G ^b   Mudo G ^b,d   Belluardo, N ^b,d   Andersson, K ^a   Agnati, L F ^c   Fuxe, K ^b  

^a MOUNT SINAI SCHOOL OF MEDICINE   (United States)

^b KAROLINSKA INSTITUTE   (Sweden)

^c UNIVERSITY OF MODENA AND REGGIO EMILIA   (Italy)

^d UNIVERSITY OF CATANIA   (Italy)

Author keywords

3,4 dihydroxy phenyl acetic acid; Dopamine; Homovanillic acid; Immunohistochemistry; RNAse protection assay; Substantia nigra

Indexed keywords

BASIC FIBROBLAST GROWTH FACTOR; MESSENGER RNA; NICOTINE; OXIDOPAMINE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BRAIN INJURY; CONTROLLED STUDY; DOPAMINERGIC NERVE CELL; IMMUNOHISTOCHEMISTRY; MALE; NONHUMAN; PARKINSON DISEASE; PRIORITY JOURNAL; RAT; SUBSTANTIA NIGRA;

ANIMAL; DOSE-RESPONSE RELATIONSHIP, DRUG; FIBROBLAST GROWTH FACTOR 2; IMMUNOHISTOCHEMISTRY; MESENCEPHALON; NICOTINE; OXIDOPAMINE; RATS; RATS, SPRAGUE-DAWLEY; RNA, MESSENGER; SUBSTANTIA NIGRA; SUPPORT, NON-U.S. GOV'T;

EID: 0029656194     PISSN: 03064522     EISSN: None     Source Type: Journal    
DOI: 10.1016/0306-4522(95)00364-O     Document Type: Article

References (43)

1. Balfour D. J. K. (1991) The neurochemical mechanisms underlying nicotine tolerance and dependence. In The Biological Bases of Drug Tolerance and Dependence (ed. Pratt J.), pp. 121-151. Academic Press, London.
2. Baron J. A. (1986) Cigarette smoking and Parkinson's disease. Neurology 36, 1490-1496.
3. Bean A. J., Elde R., Cao Y. H., Oellig C., Tamminga C., Goldstein M., Pettersson R. F. and Hökfelt T. (1991) Expression of acidic and basic fibroblast growth factors in the substantia nigra of rat, monkey, and human. Proc. natn. Acad. Sci. U.S.A. 88, 10,237-10,241.
4. Behmand R. A. and Harik S. I. (1992) Nicotine enhances 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine neurotoxicity. J. Neurochem. 58, 776-779.
5. Blum M. (1989) Regulation of neuroendocrine peptide gene expression. In Methods in Enzymology (ed. Conn P. M.), vol. 168, pp. 618-633. Academic Press, San Diego, CA.
6. Casper D., Roboz G. J. and Blum M. (1994) Epidermal growth factor and basic fibroblast growth factor have independent actions on mesencephalic dopamine neurons in culture. J. Neurochem. 62, 2166-2177.
7. Chadi G., Moller A., Rosén L., Janson A. M., Agnati L. A., Goldstein M., Ögren S.-O., Pettersson R. F. and Fuxe K. (1993) Protective actions of human recombinant basic fibroblast growth factor on MPTP-lesioned nigrostriatal dopamine neurons after intraventricular infusion. Expl Brain Res. 97, 145-158.
8. Chadi G., Rosén L., Cintra A., Tinner B., Zoli M., Pettersson R. F. and Fuxe K. (1993) Corticosterone increases FGF-2 (bFGF) immunoreactivity in the substanti nigra of the rat. NeuroReport 4, 783-786.
9. Chadi G., Cao Y., Pettersson R. F. and Fuxe K. (1994) Temporal and spatial increase of astroglial basic fibroblast growth factor synthesis after 6-hydroxydopamine-induced degeneration of the nigrostriatal dopamine neurons. Neuroscience 61, 891-910.
10. Cintra A., Cao Y. H., Oellig C., Tinner B., Bortolotti F., Goldstein M., Pettersson R. F. and Fuxe K. (1991) Basic FGF is present in dopaminergic neurons of the ventral midbrain of the rat. NeuroReport 2, 597-600.
11. Engele J. and Bohn M. C. (1991) The neurotrophic effects of fibroblast growth factors on dopaminergic neurons in vitro are mediated by mesencephalic glia. J. Neurosci. 11, 3070-3078.
12. Feeney D. M. (1991) Pharmacological modulation of recovery after brain injury: a reconsideration of diaschisis. J. Neurol. Rehabil. 5, 113-128.
13. Ferrari G., Minozzi M.-C., Toffano G., Leon A. and Skaper S. D. (1989) Basic fibroblast growth factor promotes the survival and development of mesencephalic neurons in culture. Devl Biol. 133, 140-147.
14. Florkiewicz R. Z. and Sommer A. (1989) Human basic fibroblast growth factor gene encodes four polypeptides: three initiate translation from non-AUG codons. Proc. natn. Acad. Sci. U.S.A. 86, 3978-3981.
15. Florkiewicz R. Z., Baird A. and Gonzalez A. M. (1991) Multiple forms of bFGF: differential nuclear and cell surface localization. Growth Factors 4, 265-275.
16. Fuxe K., Janson A. M., Jansson A., Andersson K., Eneroth P. and Agnati L. F. (1990) Chronic nicotine treatment increases dopamine levels and reduces dopamine utilization in substantia nigra and surviving forebrain dopamine nerve terminal systems after a partial di-mesencephalic hemitransaction. Naunyn-Schmiedeberg's Arch. Pharmc. 341, 171-181.
17. Fuxe K., Chadi G., Agnati L. F., Tinner B., Rosén L., Janson A. M., Moller A., Cintra A., Cao Y., Goldstein M., Lindahl U., David G., Øgren S., Toffano G., Baird A. and Petterson R. F. (1994) Fibroblast growth factor-2, ganglioside GM1 and the trophic regulation of the basal ganglia. Focus on the nigrostriatal dopamine neurons. In Trophic Regulation of the basal Ganglia. Focus on Dopamine Neurons (eds Fuxe K., Agnati L. F., Bjelke B. and Ottoson D.), pp. 1-41. Pergamon, Oxford.
18. Gonzalez A. M., Buscaglia M., Ong M. and Baird A. (1990) Distribution of basic fibroblast growth factor in the 18-day rat fetus: localization in the basement membranes of diverse tissues. J. Cell Biol. 110, 753-765.
19. Grenhoff J., Janson A. M., Svensson T. H. and Fuxe K. (1991) Chronic continuous nicotine treatment causes decreased burst firing of nigral dopamine neurons in rats partially hemitransected at the meso-diencephalic junction. Brain Res. 562, 347-351.
20. Hadjiconstantinou M., Hubble J. P., Wemlinger T. A. and Neff N. H. (1994) Enhanced MPTP neurotoxicity after treatment with isoflurophate or cholinergic agonists. J. Pharmac. exp. Ther. 270, 639-644.
21. Ishikawa A. and Miyatake T. (1993) Effects of smoking in patients with early-onset Parkinson's disease. J. Neural. Sci. 117, 28-32.
22. Janson A. M., Fuxe K., Kitayama I., Härfstrand A. and Agnati L. F. (1986) Morphometric studies on the protective action of nicotine on the substantia nigra dopamine nerve cells after partial hemitransection in the male rat. Neurosci. Lett., Suppl. 26, S88.
23. Janson A. M., Fuxe K., Agnati L. F., Kitayama I., Härfstrand A., Andersson K. and Goldstein M. (1988) Chronic nicotine treatment counteracts the disappearance of tyrosine-hydroxylase-immunoreactive nerve cell bodies, dendrites and terminals in the mesostriatal dopamine system of the male rat after partial hemitransection. Brain Res. 455, 332-345.
24. Janson A. M., Meana J. J., Goiny M. and Herrera-Marschitz M. (1991) Chronic nicotine treatment counteracts the decrease in extracellular neostriatal dopamine induced by a unilateral transection at the mesodiencephalic junction in rats: a microdialysis study. Neurosci. Lett. 134, 88-92.
25. Janson A. M., Fuxe K. and Goldstein M. (1992) Differential effects of acute and chronic nicotine treatment on MPTP-(1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine) induced degeneration of nigrostriatal dopamine neurons in the black mouse. Clin. Invest. 70, 232-238.
26. Janson A. M. and Moller A. (1993) Chronic nicotine treatment counteracts nigral cell loss induced by a partial mesodiencephalic hemitransection: an analysis of the total number and mean volume of neurons and glia in substantia nigra of the male rat. Neuroscience 57, 931-941.
27. Janson A. M., Møller A., Hedlund P. B., von Euler G. and Fuxe K. (1995) Nicotine and animal models of Parkinson's disease. In Effects of Nicotine on Biological Systems: II - Advances in Pharmacological Sciences, pp. 321-328. Birkhäuser, Basel.
28. Keller R., Oke A., Mefford I. and Adams R. N. (1976) Liquid chromatographic analysis of catecholamines routine assay for regional brain mapping. Life Sci. 19, 995-1003.
29. König J. R. R. and Klippel R. A. (1963) The Rat Brain. A Stereotaxic Atlas of the Forebrain and Lower Parts of the Brain Stem. Krieger, New York.
30. Lapchak P. A., Araujo D. M. and Hefti F. (1993) Cholinergic regulation of hippocampal brain-derived neurotrophic factor mRNA expression: evidence from lesion and chronic cholinergic drug treatment studies. Neuroscience 52, 575-585.
31. Luthman J. (1989) Neonatal dopamine lesions: morphological, biochemical and behavioural characterization (thesis). Karolinska Institute, Stockholm.
32. Matsuzaki K., Yoshitake Y., Matuo Y., Sasaki H. and Nishikawa K. (1989) Monoclonal antibodies against heparin-binding growth factor II/basic fibroblast growth factor that block its biological activity: invalidity of the antibodies for tumor angiogenesis. Proc. natn. Acad. Sci. U.S.A. 86, 9911-9915.
33. Monteggia L. M., Arneric S. P. and Giordano T. (1994) Nicotine effects on the regulation of amyloid precursor protein splicing, neurotrophin and glucose transporter RNA levels in aged rats. Int. J. devl Neurosci. 12, 133-141.
34. Otto D. and Unsicker K. (1990) Basic FGF reverses chemical and morphological deficits in the nigrostriatal system of MPTP-treated mice. J. Neurosci. 10, 1912-1921.
35. +: specificity and impact of culture conditions, non-dopaminergic neurons, and astroglia cell. J. Neurosci. Res. 34, 382-393.
36. Owman C., Fuxe K., Janson A. M. and Kåhrström J. (1989) Chronic nicotine treatment eliminates asymmetry in striatal glucose utilization following unilateral transection of the mesostriatal dopamine pathway in rats. Neurosci. Lett. 102, 279-283.
37. +-damaged dopaminergic fibers by treatment of mesencephalic cultures with EGF and basic FGF. Brain Res. 599, 83-97.
38. Shimasaki S., Emoto N., Koba A., Mercado M., Shibata F., Cooksey K., Baird A. and Ling N. (1988) Complementary DNA cloning and sequencing of rat ovarian basic fibroblast growth factor and tissue distribution study of its mRNA. Biochem. biophys. Res. Commun. 157, 256-263.
39. Stachowiak M. K., Moffett J., Joy A., Puchacz E., Florkiewicz R. and Stachowiak E. K. (1994) Regulation of bFGF gene expression and subcellular distribution of bFGF protein in adrenal medullary cells. J. Cell Biol. 127, 203-223.
40. Ungerstedt U. (1971) Striatal dopamine release after amphetamine or nerve degeneration revealed by rotational behaviour. Acta physiol., Scand., Suppl. 367, 49-68.
41. Ungerstedt U. and Arbuthnott G. W. (1970) Quantitative recording of rotational behavior in rats after 6-hydroxy-dopamine lesions of the nigrostriatal dopamine system. Brain Res. 24, 485-493.
42. Zamboni I. and DeMartino C. (1967) Buffered picric acid formaldehyde: a new rapid fixative for electron microscopy. J. Cell Biol. 35, 148A.
43. Zoli M., Zini I., Agnati L. F., Guidolin D., Ferraguti F. and Fuxe K. (1990) Aspects of neural plasticity in the central nervous system. I. Computer-assisted image analysis methods. Neurochem. Int. 16, 383-418.